John Somberg to Drug Evaluation
This is a "connection" page, showing publications John Somberg has written about Drug Evaluation.
Connection Strength
0.307
-
International symposium on drug development. Am J Ther. 1999 Sep; 6(5):289.
Score: 0.181
-
Class effects of pharmaceuticals and therapeutic interchangeability. Am J Ther. 2001 Jul-Aug; 8(4):221-2.
Score: 0.051
-
Encainide: a new and potent antiarrhythmic. Am Heart J. 1987 Oct; 114(4 Pt 1):826-35.
Score: 0.020
-
Lorcainide therapy for the high-risk patient post myocardial infarction. Am J Cardiol. 1984 Aug 13; 54(4):37B-42B.
Score: 0.016
-
Evaluation of lorcainide in patients with symptomatic ventricular tachycardia. Am J Cardiol. 1984 Aug 13; 54(4):43B-48B.
Score: 0.016
-
Comparison of noninvasive arrhythmia induction techniques with electrophysiologic studies and evaluation of lorcainide in patients with symptomatic ventricular tachycardia. Am J Cardiol. 1984 Aug 13; 54(4):49B-54B.
Score: 0.016
-
Pharmacokinetics of oral cibenzoline in arrhythmia patients. Clin Pharmacokinet. 1985 Mar-Apr; 10(2):178-86.
Score: 0.004
-
Cibenzoline plasma concentration and antiarrhythmic effect. Clin Pharmacol Ther. 1984 Mar; 35(3):307-16.
Score: 0.004